InvestorsHub Logo
Followers 10
Posts 1418
Boards Moderated 0
Alias Born 08/08/2015

Re: HDGabor post# 115451

Wednesday, 10/04/2017 8:35:48 AM

Wednesday, October 04, 2017 8:35:48 AM

Post# of 426452

The bipolarity on the board is interesting: V isn't about TG lowering, more than TG lowering (e.g. inflammation) on one hand, but should be approved based on TG lowering on the other hand ...



The bipolarity on the board is not an Anchor issue. Has nothing to do with ANCHOR. If the FDA felt that lowering trigs in the 200-500 range was worthless then why accept NDA for ANCHOR? Why agree on an SPA? There was no credible science in the period after the SPA came out which would refute the clinical benefit of lowering trigs in the 200-500 class and allow the FDA the "out" they used.

I agree with zip 100%.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News